GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Market Cap

Actinogen Medical (ASX:ACW) Market Cap : A$92.20 Mil (As of Dec. 12, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Actinogen Medical's share price for the quarter that ended in Dec. 2023 was A$0.021699. Actinogen Medical's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 2,339.29 Mil. Therefore, Actinogen Medical's market cap for the quarter that ended in Dec. 2023 was A$50.76 Mil.

Actinogen Medical's quarterly market cap declined from Dec. 2022 (A$180.62 Mil) to Jun. 2023 (A$72.65 Mil) and declined from Jun. 2023 (A$72.65 Mil) to Dec. 2023 (A$50.76 Mil).

Actinogen Medical's annual market cap declined from Jun. 2022 (A$89.78 Mil) to Jun. 2023 (A$72.65 Mil) but then increased from Jun. 2023 (A$72.65 Mil) to Jun. 2024 (A$166.35 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Actinogen Medical's Enterprise Value for Today is A$83.07 Mil.


Actinogen Medical Market Cap Historical Data

The historical data trend for Actinogen Medical's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Market Cap Chart

Actinogen Medical Annual Data
Trend Jun14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.56 215.87 89.78 72.65 166.35

Actinogen Medical Semi-Annual Data
Jun14 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 89.78 180.62 72.65 50.76 166.35

Competitive Comparison of Actinogen Medical's Market Cap

For the Biotechnology subindustry, Actinogen Medical's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actinogen Medical's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's Market Cap distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's Market Cap falls into.



Actinogen Medical Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Actinogen Medical's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as

Market Cap (A: Jun. 2024 )=Share Price (A: Jun. 2024 )*Shares Outstanding (EOP) (A: Jun. 2024 )
=A$0.062*2683.05
=A$166.35

Actinogen Medical's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )=Share Price (Q: Dec. 2023 )*Shares Outstanding (EOP) (Q: Dec. 2023 )
=A$0.021699*2339.29
=A$50.76

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actinogen Medical  (ASX:ACW) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Actinogen Medical Market Cap Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Actinogen Medical Business Description

Traded in Other Exchanges
Address
109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000
Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. It is focused on the clinical development of Xanamem, an oral medication for neurological diseases amenable to its mechanism of lowering cortisol in brain cells. Geographically, the company's income is derived in Australia.

Actinogen Medical Headlines

From GuruFocus

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish 10-13-2014

Stocks That Are Making A Good Come Back

By reports.droy reports.droy 03-10-2015